Agreement between predicted risk and prevalence of Down syndrome in second-trimester triple-marker screening in Japan

被引：0

作者：

Onda, T

Tanaka, T

Takeda, O

Kitagawa, M

Kuwabara, Y

Yamamoto, H

Iinuma, K

Shimomura, K

机构：

[1] Jikei Univ, Sch Med, Dept Obstet & Gynaecol, Tokyo 105, Japan

[2] Fuji City Hosp, Fuji, Shizuoka, Japan

[3] Natl Ohkura Hosp, Tokyo, Japan

[4] Juntendo Univ, Sch Med, Tokyo 113, Japan

[5] Sapporo Med Univ, Sch Med, Sapporo, Hokkaido, Japan

[6] IG Clin, Tokyo, Japan

[7] Genzyme Japan KK, Tokyo, Japan

来源：

PRENATAL DIAGNOSIS | 1998年 / 18卷 / 09期

关键词：

triple-marker screening test; Down syndrome; prediction; accuracy; follow-up study;

D O I：

10.1002/(SICI)1097-0223(199809)18:9<956::AID-PD370>3.0.CO;2-R

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Based on 9350 pregnant Japanese women who were screened by serum triple-marker determination, accuracy of predicted risk for Down syndrome was examined using 24 Down syndrome cases detected either prenatally or postnatally. The correlation is statistically very high (r=0.98) between the predicted risks and the prevalence of Down syndrome cases. Here we emphasize that this could be accomplished only by an extensive follow-up study, implemented in our prospective intervention programme. (C) 1998 John Wiley & Sons, Ltd.

引用

页码：956 / 958

页数：3

共 36 条

[21] ADAM12 is an effective marker in the second trimester of pregnancy for prenatal screening of Down syndrome
Wang, Min
Lu, Shiming
Zhu, Yuning
Li, Hui
PRENATAL DIAGNOSIS, 2010, 30 (06) : 561 - 564
[22] Defining nasal bone hypoplasia in second-trimester Down syndrome screening: does the use of multiples of the median improve screening efficacy?
Odibo, Anthony O.
Sehdev, Harish M.
Stamilio, David M.
Cahill, Alison
Dunn, Linda
Macones, George A.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (04) : 361.e1 - 361.e4
[23] SECOND-TRIMESTER MATERNAL SERUM QUADRUPLE TEST FOR DOWN SYNDROME SCREENING: A TAIWANESE POPULATION-BASED STUDY
Shaw, S. W. Steven
Lin, Shin-Yu
Lin, Chia-Hui
Su, Yi-Ning
Cheng, Po-Jen
Lee, Chien-Nan
Chen, Chih-Ping
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2010, 49 (01): : 30 - 34
[24] Levels of urinary beta-core fragment, total oestriol, and the ratio of the two in second-trimester screening for Down syndrome
Kellner, LH
Canick, JA
Palomaki, GE
Neveux, LM
Saller, DN
Walker, RP
Osathanondh, R
Bombard, AT
PRENATAL DIAGNOSIS, 1997, 17 (12) : 1135 - 1141
[25] Nuchal translucence incorporated into a one-stage multifactorial screening model for down syndrome prediction at second-trimester pregnancy
Hung, JH
Fu, CY
Yuan, CC
Chen, CL
Yang, ML
Shu, LP
Wu, CC
ULTRASOUND IN MEDICINE AND BIOLOGY, 2003, 29 (12) : 1667 - 1674
[26] Contingent triple-screening for Down syndrome in the second trimester: a feasibility study in Mainland Chinese population
Xie, Zhenwei
Lu, Shiming
Li, Hui
PRENATAL DIAGNOSIS, 2010, 30 (01) : 74 - 76
[27] Down syndrome screening in the first and/or second trimester: Model predicted performance using meta-analysis parameters
Cuckle, H
Benn, P
Wright, D
SEMINARS IN PERINATOLOGY, 2005, 29 (04) : 252 - 257
[28] Using Second Trimester Ultrasound and Maternal Serum Biomarker Data to Help Detect Congenital Heart Defects in Pregnancies With Positive Triple-Marker Screening Results
Jelliffe-Pawlowski, Laura L.
Walton-Haynes, Lynn
Currier, Robert J.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2008, 146A (19) : 2455 - 2467
[29] Inaccurate estimation of risk in second trimester serum screening for Down syndrome among women who have already had first trimester screening
Hackshaw, AK
Wald, NJ
PRENATAL DIAGNOSIS, 2001, 21 (09) : 741 - 746
[30] Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies
Huang, Tianhua
Boucher, Karen
Summers, Anne M.
PRENATAL DIAGNOSIS, 2007, 27 (12) : 1138 - 1142

← 1 2 3 4 →